IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 238 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $243,680 | -39.1% | 53,556 | -5.7% | 0.00% | 0.0% |
| Q2 2023 | $399,872 | +46.5% | 56,800 | +129.9% | 0.00% | 0.0% |
| Q2 2022 | $273,000 | -62.7% | 24,704 | -35.5% | 0.00% | -50.0% |
| Q4 2021 | $731,000 | +45.3% | 38,284 | +88.0% | 0.00% | 0.0% |
| Q3 2021 | $503,000 | -75.3% | 20,369 | -73.9% | 0.00% | -75.0% |
| Q2 2021 | $2,033,000 | -2.2% | 78,127 | +19.0% | 0.01% | -11.1% |
| Q1 2021 | $2,078,000 | -0.7% | 65,638 | -6.1% | 0.01% | -43.8% |
| Q1 2020 | $2,093,000 | – | 69,924 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,944,201 | $27,999,000 | 13.31% |
| Broadfin Capital, LLC | 4,328,303 | $41,162,000 | 8.50% |
| GREAT POINT PARTNERS LLC | 5,567,348 | $52,945,000 | 5.24% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $20,811,000 | 5.01% |
| Avoro Capital Advisors LLC | 10,530,862 | $100,148,000 | 4.33% |
| Prosight Management, LP | 917,080 | $8,721,000 | 3.82% |
| Perceptive Advisors | 12,235,811 | $116,362,000 | 3.28% |
| Ghost Tree Capital, LLC | 1,150,000 | $10,937,000 | 2.86% |
| QVT Financial LP | 1,021,361 | $9,241,000 | 2.32% |
| Cheyne Capital Management (UK) LLP | 186,500 | $1,774,000 | 1.66% |